Unclear boundaries between investigator-controlled and sponsor-managed data in IRT systems are creating avoidable compliance risk, particularly around investigational product inventory and quality actions.
Mohammed Najmul Hasan, MPharm
Advertisement
Clinical Trial Supply Manager, Novartis
Articles by Mohammed Najmul Hasan, MPharm
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
IgniteData and RealTime Partner to Streamline Clinical Data Transfer From eSource to Sponsor Systems
2
The Biggest Remaining Barriers to High-Quality RWE Across Oncology Data Platforms
3
ACT Brief: Design Drivers of Trial Representation, eSource-to-EDC Data Automation, and Roche's ALK7 Obesity License
4
Flexible Clinical Operations and Site Management Across a Diversified Biotech Portfolio: An Application of Quality by Design and Risk-Based Oversight
5